The global Tuberculosis Vaccine Market is estimated to driven by Increasing incidence of drug-resistant TB cases

Tuberculosis (TB) vaccine development is witnessing rapid advancements driven by growing demand. Tuberculosis vaccines aim to provide protection against Mycobacterium tuberculosis, the bacteria that causes TB. As TB is a major cause of death worldwide and existing Bacillus Calmette-Guerin (BCG) vaccine provides limited protection, there is a huge clinical need for more effective TB vaccines. Several candidates including VPM1002, MVA85A, and DAR-901 are currently in clinical trials. These vaccines rely on new strategies like viral vectored delivery or inclusion of additional antigens to induce stronger and longerlasting immune responses compared to BCG.

The global Tuberculosis Vaccine Market is estimated to be valued at US$ 350 million in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024–2031.

Key Takeaways

Key players: Key players operating in the Tuberculosis Vaccine market are Serum Institute of India, AJ Vaccines, BioFabri, Merck & Co. and Mylan.

Growing demand:

The increasing incidence of drug-resistant TB cases globally is fueling Tuberculosis Vaccine Market demand for improved vaccines. As per WHO estimates, around 10 million people fell ill with TB in 2020.

Global expansion: Major players are investing in clinical trials across different geographies and expanding manufacturing capacities to cater to the large patient population in high burden countries in Asia and Africa.

Market Key Trends

Viral vectored vaccines are gaining significant traction in the TB vaccine pipeline. Candidates like VPM1002 and MVA85A utilize adenoviral vectors to deliver TB antigens and induce broad, long-lasting immune responses. Early clinical trial data has demonstrated their safety and efficacy which can potentially enable their deployment alongside BCG in the future. As these new generation vaccines progress through late-stage trials in the coming years, they are expected to contribute significantly to preventing TB infections worldwide if approved.

Porter’s Analysis

Threat of new entrants: The threat of new entrants into the market is high as development of new tuberculosis vaccines requires huge investments and clinical trials which may take several years.

Bargaining power of buyers: The bargaining power of buyers is moderate as the demand for tuberculosis vaccines comes from governments and not individual consumers.

Bargaining power of suppliers: A few large players dominate the supply side in this market.

Hence bargaining power of suppliers is high.

Threat of new substitutes: Currently, there are no effective substitutes for tuberculosis vaccines, and the threat from new substitutes is low, highlighting Tuberculosis Vaccine Market Challenges and Opportunities compete on the basis of vaccine efficacy and ability to cater to specific genotypes of tuberculosis.

Geographical Regions

Currently, the tuberculosis vaccine market in terms of value is highly concentrated in Asia Pacific and Africa regions. This is due to the high disease burden of tuberculosis in countries like India, China, Indonesia, Philippines, Pakistan etc.

The fastest growing region for the tuberculosis vaccine market is expected to be Asia Pacific. Factors such as improving healthcare infrastructure, rising awareness about tuberculosis prevention, increasing government expenditures on immunization programs in countries like India and China will support the growth of the tuberculosis vaccine market in the Asia Pacific region.

French German Italian Russian Japanese Chinese Korean Portuguese

Get More Insights On  Tuberculosis Vaccine Market
https://www.insightprobing.com/tuberculosis-vaccine-market-poised-to-expand/

About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)